ESR1 and metabolic dysfunction-associated steatotic liver disease: Genistein has a similar structure to 17β-estradiol and can stimulate the transcriptional activity of estrogen receptor alpha and beta which makes it an attractive alternative to estrogen replacement therapy in post-menopausal women with NAFLD [29].